SHSCX BlackRock Health Sciences Opps Inv C Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Abbott Laboratories (NYSE:ABT), Merck & Co (NYSE:MRK), Intuitive Surgical (NASDAQ:ISRG), Amgen (NASDAQ:AMGN), Boston Scientific Corp (NYSE:BSX).

The investment seeks to provide long-term growth of capital. The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

The average market capitalization across the BlackRock Health Sciences Opps Inv C MF is 250.49B. The market cap for tickers in the group ranges from 141.33B to 684B. LLY holds the highest valuation in this group at 684B. The lowest valued company is SYK at 141.33B.

The average weekly volume growth across all stocks in the BlackRock Health Sciences Opps Inv C MF was -6%. For the same stocks of the MF, the average monthly volume growth was 21% and the average quarterly volume growth was 11%